Search results
US FDA approves Bristol Myers' colorectal cancer therapy - ET HealthWorld | Pharma
The Economic Times· 5 days agoLondon: The U.S. Food and Drug Administration has approved Bristol Myers Squibb's combination...
BMS expands Krazati’s FDA label to include colorectal cancer
Clinical Trials Arena· 2 days agoKrazati pulled in $21m in sales in the first quarter of this year, per BMS financials. It is...
Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III...
Clinical Trials Arena· 3 days agoThe Connecticut, US-headquartered company released a press release announcing the Phase I trial...
ASCO24: Novartis’ Scemblix outperforms standard of care in CML
Pharmaceutical Technology· 2 days ago“When you combine superior response with the excellent safety and tolerability profile...
ASCO24: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Pharmaceutical Technology· 2 days agoFollowing the positive results, the company now plans to start a global Phase III clinical trial...
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
BioPharma Dive· 6 days agoA medicine Jazz acquired in 2019 missed the goal of a Phase 2 study. Elsewhere, Vanda rejected two...
For the next big leap, leading Indian CDMOs mull a new policy advocacy group - ET HealthWorld |...
The Economic Times· 3 days agoHyderabad: Leading Indian CDMOs (contract development and manufacturers organization) are close to...
When Yusuf Hamied defied Big Pharma in the battle against HIV/AIDS
Livemint· 5 days agoSeated amidst the heavyweights of global pharma like Merck and Glaxo was an oddity, an Indian...
Scientifically Speaking | Remembering Akira Endo, the scientist who revolutionised heart care
Hindustan Times· 3 days ago"For me, Fleming was a hero," Endo said to the Japanese medical publisher Igaku-Shoin in 2014 (as...
Therapy developer Alumis seeks up to $1 bln valuation in US IPO - ET HealthWorld
The Economic Times· 3 days agoLondon: Alumis is targeting a valuation of up to $1.01 billion in its initial public offering in the...